Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Zeft

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Rheumatology International|March 9, 2017
Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndromeKalpana Manthiram, Suzanne C Li, Jonathan S Hausmann, et al.
Clinical and Experimental Rheumatology|March 31, 2018
The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart reviewSusan Shenoi, Gerd Horneff, Michal Cidon, et al.
Pediatric Rheumatology Online Journal|June 27, 2018
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritisDaniel J Lovell, Jason A Dare, Megan Francis-Sedlak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2021
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic PolyangiitisPaul Brogan, Rae S M Yeung, Gavin Cleary, et al.
Arthritis Care & Research|October 11, 2016
International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D SyndromeSeza Ozen, Jasmin B Kuemmerle-Deschner, Rolando Cimaz, et al.
Arthritis and Rheumatism|February 1, 2011
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter seriesPeter A Nigrovic, Melissa Mannion, Femke H M Prince, et al.
Rheumatology (Oxford, England)|January 20, 2024
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registryDaniel J Lovell, Nikolay Tzaribachev, Michael Henrickson, et al.
Arthritis Care & Research|April 17, 2012
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized sclerodermaSuzanne C Li, Kathryn S Torok, Elena Pope, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label studyHermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, et al.
The Journal of Rheumatology|August 5, 2025
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Rheumatology International|March 9, 2017
Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndromeKalpana Manthiram, Suzanne C Li, Jonathan S Hausmann, et al.
Clinical and Experimental Rheumatology|March 31, 2018
The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart reviewSusan Shenoi, Gerd Horneff, Michal Cidon, et al.
Pediatric Rheumatology Online Journal|June 27, 2018
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritisDaniel J Lovell, Jason A Dare, Megan Francis-Sedlak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2021
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic PolyangiitisPaul Brogan, Rae S M Yeung, Gavin Cleary, et al.
Arthritis Care & Research|October 11, 2016
International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D SyndromeSeza Ozen, Jasmin B Kuemmerle-Deschner, Rolando Cimaz, et al.
Arthritis and Rheumatism|February 1, 2011
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter seriesPeter A Nigrovic, Melissa Mannion, Femke H M Prince, et al.
Rheumatology (Oxford, England)|January 20, 2024
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registryDaniel J Lovell, Nikolay Tzaribachev, Michael Henrickson, et al.
Arthritis Care & Research|April 17, 2012
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized sclerodermaSuzanne C Li, Kathryn S Torok, Elena Pope, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label studyHermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, et al.
The Journal of Rheumatology|August 5, 2025
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
Pageof 3